Clinical impact of baseline renal function on the safety of radiotherapy with concurrent docetaxel for esophageal cancer

  • PDF / 692,257 Bytes
  • 8 Pages / 595.276 x 790.866 pts Page_size
  • 55 Downloads / 130 Views

DOWNLOAD

REPORT

ORIGINAL ARTICLE

Clinical impact of baseline renal function on the safety of radiotherapy with concurrent docetaxel for esophageal cancer in elderly patients Terufumi Kawamoto1 · Naoto Shikama1 · Shinji Mine2 · Masahiko Tsurumaru2 · Keisuke Sasai1 Received: 23 December 2019 / Accepted: 4 March 2020 © The Japan Esophageal Society 2020

Abstract Background  We aimed to compare the safety of radiotherapy with concurrent docetaxel (DOC-RT) for esophageal cancer (EC) in elderly patients who were divided into a creatinine clearance (Ccr) 

Data Loading...

Recommend Documents
Clinical Aspect: Esophageal Cancer

180 98 900KB

Clinical Implications of Renal Cancer

150 95 20MB

Clinical outcomes of retrograde intra-arterial chemotherapy concurrent with radiotherapy for elderly oral squamous cell

152 73 667KB

S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy for stage III non-sm

153 85 573KB

The impact of 4DCT-ventilation imaging-guided proton therapy on stereotactic body radiotherapy for lung cancer

137 48 835KB

Esophageal Adenocarcinoma with Solitary Renal Metastasis

171 16 113KB

Esophageal Cancer: Background and Clinical Evidence

156 109 449KB

Collaborative Learning of Cross-channel Clinical Attention for Radiotherapy-Related Esophageal Fistula Prediction from C

121 11 126MB

Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma

181 86 1MB

Role of a multidisciplinary team in administering radiotherapy for esophageal cancer

131 20 564KB

Radiotherapy for Prostate Cancer

199 8 7MB

Surgery of esophageal cancer

171 59 118KB